Literature DB >> 28497708

Salivary Gland Secretory Carcinoma With High-Grade Transformation, CDKN2A/B Loss, Distant Metastasis, and Lack of Sustained Response to Crizotinib.

Nicole A Cipriani1, Elizabeth A Blair1, Joshua Finkle1, Jennifer L Kraninger1, Christopher M Straus1, Victoria M Villaflor2, Daniel Thomas Ginat1.   

Abstract

BACKGROUND: Salivary gland secretory carcinoma is usually a low-grade neoplasm. However, high-grade transformation can occur and has important implications for clinical outcome.
METHODS: A patient presented with an enlarging buccal mass. Magnetic resonance imaging (MRI) showed a tumor with a biphasic appearance along the right parotid duct. Local excision and histopathologic examination confirmed the diagnosis of secretory carcinoma with high-grade transformation. ETV6-NTRK3 translocation and loss of CDKN2A/B were identified.
RESULTS: The patient subsequently presented with cough and dyspnea and was found to have pleural metastases. Carboplatin and paclitaxel exacerbated the symptoms. Crizotinib resulted in initial symptomatic and radiographic improvement; however, the patient soon succumbed to progressive intrathoracic disease.
CONCLUSIONS: High-grade salivary gland secretory carcinoma can have a biphasic appearance on MRI. Diagnosis is confirmed by the histologic appearance and associated ETV6-NTRK3 fusion. Additional molecular genetic events leading to transformation are unknown; however, loss of CDKN2A/B may have contributed. Treatment with multimodal chemotherapy was of limited benefit.

Entities:  

Keywords:  CDKN2A/B; MRI; crizotinib; high grade; metastatic; salivary gland; secretory carcinoma

Mesh:

Substances:

Year:  2017        PMID: 28497708     DOI: 10.1177/1066896917709350

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  10 in total

1.  Educational Impact of Trainee-Facilitated Head and Neck Radiology-Pathology Correlation Conferences.

Authors:  Daniel Thomas Ginat; Nicole A Cipriani; Gregory Christoforidis
Journal:  Head Neck Pathol       Date:  2018-05-17

2.  Secretory carcinoma of the salivary gland: a multi-institutional clinicopathologic study of 90 cases with emphasis on grading and prognostic factors.

Authors:  Bin Xu; Kartik Viswanathan; Kavita Umrau; Thair A D Al-Ameri; Snjezana Dogan; Kelly Magliocca; Ronald A Ghossein; Nicole A Cipriani; Nora Katabi
Journal:  Histopathology       Date:  2022-09-05       Impact factor: 7.778

3.  Sinonasal Secretory Carcinoma of Salivary Gland with High Grade Transformation: A Case Report of this Under-Recognized Diagnostic Entity with Prognostic and Therapeutic Implications.

Authors:  Bin Xu; Ruth Aryeequaye; Lu Wang; Nora Katabi
Journal:  Head Neck Pathol       Date:  2017-10-04

4.  High Grade Transformation in Mucoepidermoid Carcinoma of the Minor Salivary Gland with Polyploidy of the Rearranged MAML2 Gene.

Authors:  Hyun Lee; Jong-Lyel Roh; Young-Jun Choi; Jene Choi; Kyung-Ja Cho
Journal:  Head Neck Pathol       Date:  2019-09-18

5.  High-grade Salivary Gland Adenocarcinoma Harboring ETV6-NTRK3 Fusion: Defined by Morphology or Molecular Aberration?

Authors:  Niels J Rupp; Constanze Nemes; Elisabeth J Rushing; Gerhard F Huber; Sandra N Freiberger
Journal:  Head Neck Pathol       Date:  2021-02-05

6.  A "Null" Pattern of p16 Immunostaining in Endometrial Serous Carcinoma: An Under-recognized and Important Aberrant Staining Pattern.

Authors:  Daniel R Matson; Molly A Accola; Les Henderson; Xiangqiang Shao; Leah Frater-Rubsam; Vanessa L Horner; William M Rehrauer; Paul Weisman; Jin Xu
Journal:  Int J Gynecol Pathol       Date:  2021-08-11       Impact factor: 3.326

Review 7.  Secretory carcinoma: the eastern Canadian experience and literature review.

Authors:  David Forner; Martin Bullock; Daniel Manders; Timothy Wallace; Christopher J Chin; Liane B Johnson; Matthew H Rigby; Jonathan R Trites; Mark S Taylor; Robert D Hart
Journal:  J Otolaryngol Head Neck Surg       Date:  2018-11-16

8.  Clinicopathological characteristics and outcomes of 23 patients with secretory carcinoma of major salivary glands.

Authors:  Jingjing Sun; Sirui Liu; Kun Fu; Ning Gao; Rui Li; Wei He; Zhenjie Gao
Journal:  Sci Rep       Date:  2021-11-22       Impact factor: 4.379

9.  Clinicopathological investigation of secretory carcinoma cases including a successful treatment outcome using entrectinib for high-grade transformation: a case report.

Authors:  Kensuke Suzuki; Hiroshi Harada; Masayuki Takeda; Chisato Ohe; Yoshiko Uemura; Akihiko Kawahara; Shunsuke Sawada; Akira Kanda; Bhaswati Sengupta; Hiroshi Iwai
Journal:  BMC Med Genomics       Date:  2022-01-06       Impact factor: 3.063

Review 10.  An Underappreciated Cytomorphological Feature of Secretory Carcinoma of Salivary Gland on Fine Needle Aspiration Biopsy: Case Report with Literature Review.

Authors:  Yinan Hua; Bing Leng; Kenneth E Youens; Lina Liu
Journal:  Head Neck Pathol       Date:  2021-07-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.